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It is widely believed that epithelial stem cells reside in
the hair follicle bulge region.We investigated the hema-
topoietic stem and progenitor cell marker, CD34, as a
potential marker of hair follicle bulge keratinocytes.
Using a CD34-speci¢c antibody, we identi¢ed intense
membrane staining on keratinocytes in the bulge
region of the mouse hair follicle. CD34 expression colo-
calized with both slowly cycling (label retaining) cells
and keratin 15 expression. Live CD34þ keratinocytes
were positively selected using antibodies to CD34 and
a6 integrin in combination with £uorescent activated
cell sorting. Sorted cells were analyzed for DNA
content, and a staining pro¢le was generated to con¢rm
these cells as keratinocytes. CD34þ keratinocytes were
predominantly in Go/G1, in contrast to CD34
^ cells,
which had well de¢ned G2/M and S phases. In addition,
CD34þ keratinocytes were found to express a6 integrin
more intensely than CD34^ cells (po0.05), identifying
this population as an a6 integrin bright subset. When
seeded at clonal density, CD34þ keratinocytes formed
larger colonies than CD34^ cells (po0.05), indicating a
higher proliferative potential. All £ow-sorted cells were
positive for keratin 14 expression, and negative for kera-
tin 1, loricrin, vimentin, and CD31. The majority of
CD34þ cells (98%) were positive for keratin 6, establish-
ing this population as basal keratinocytes of follicular
origin. CD34 message was detected by reverse tran-
scription polymerase chain reaction predominantly in
the CD34þ keratinocytes, con¢rming speci¢city of the
antibody. This work is the ¢rst to demonstrate that
CD34 is a speci¢c marker of bulge cell keratinocytes in
the cutaneous epithelium. Furthermore, the use of this
marker facilitates isolation of live epithelial cells with
stem and progenitor cell characteristics, potentially
providing a tool for the study of carcinogen target cells,
gene therapy, and tissue engineering applications. Key
words: epidermal/keratinocyte/stem cell. J Invest Dermatol
120:501 ^511, 2003
T
he epidermis is a continually renewing tissue consist-
ing of a large population of transit amplifying (TA)
cells with limited proliferative capacity, and a smaller
population of keratinocyte stem cells (KSCs) that
have a high proliferative potential and are clonogenic
(Potten, 1983; Watt, 1998; Lavker and Sun, 2000). KSCs give rise
toTA cells as well as renewing the stem cell population, whereas
TA cells divide a limited number of times and are displaced to the
suprabasal layers where they are lost by terminal di¡erentiation
(Potten, 1983; Lavker et al, 1993; Morris and Potten, 1994; Watt,
1998). Stem cells typically reside in a niche within the tissue
architecture where they are protected from environmental dam-
age or physical injury (Cotsarelis et al, 1990; 1999; Morris and
Potten, 1994; Spradling et al, 2001). In the skin, it is widely
believed that the bulge region of the hair follicle is the location
of KSCs (Cotsarelis et al, 1990; Morris and Potten, 1994). A num-
ber of factors support this belief: the bulge is a well-protected
structure that remains una¡ected by normal hair cycling or
damage (Cotsarelis et al, 1990); it is the site of slowly cycling
cells having a high proliferative capacity (Cotsarelis et al, 1990;
Morris and Potten, 1994); and bulge cells have been shown to be
multipotent (Taylor et al, 2000; Oshima et al, 2001). Additionally,
the bulge region is biochemically distinct, with keratin 15 (K15)
expressed almost exclusively in bulge keratinocytes (Lyle et al,
1998; 1999), and ¢nally, bulge keratinocytes do not express the
transferrin receptor (CD71) (Tani et al, 2000), a marker of actively
cycling cells (Schwarting and Stein, 1989). Therefore, it is highly
likely that the bulge region is the location of multipotent KSCs.
Isolation of keratinocyte stem cells may lead to a better under-
standing of homeostasis and response to hyperproliferative stimu-
li and carcinogenesis, as well as to more e¡ective approaches for
gene therapy and tissue engineering applications. Only a limited
number of cell surface markers for keratinocyte stem cells have
been identi¢ed, however, with none selecting positively for bulge
cells. Keratinocytes with stem cell characteristics have been
enriched using £uorescence activated cell sorting (FACS)
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following immunostaining for b1 integrin (Jones andWatt, 1993).
This determinant comprises a large population of keratinocytes,
however, including basal and suprabasal; thus the population is
far from pure. Li et al (1998) suggested that a6 integrin might be
employed as a tool for isolating KSCs due to its expression only
on basal keratinocytes at the point of contact with the basement
membrane (Sonnenberg et al, 1991; Li et al, 1998). Because the hair
follicle outer root sheath is contiguous with the interfollicular
epidermis, a6 integrin captures hair follicle keratinocytes, includ-
ing bulge cells. They found no clear subsets within the a6-ex-
pressing population, however. Tani et al (2000) reported a
negative selection method using double staining with CD71, the
transferrin receptor, which expressed only by cycling cells
(Schwarting and Stein, 1989), and a6 integrin. Selection of
a6briCD71dim cells enriched for slowly cycling label retaining
cells (LRCs), whereas a6briCD71bri cells were enriched for rapidly
cycling TA cells, thus providing a selectable determinant for
KSCs (Tani et al, 2000). CD71 has limited usefulness as a marker
of bulge keratinocytes, however, due to its expression on epider-
mal as well as follicular keratinocytes.
CD34 is a 105^120 kDa glycoprotein expressed on early hema-
topoietic progenitor cells and is widely used as part of the selec-
tion process to obtain stem cells for autologous bone marrow
transplants (Brown et al, 1991; Krause et al, 1994; Young et al,
1995). CD34 expression is also found in several nonhematopoietic
tissues, including skeletal muscle (Lee et al, 2000), gastrointestinal
tract (Vanderwinden et al, 2000), and endothelial cells (Young
et al, 1995). Here, we report that CD34 expression in mouse kera-
tinocytes of the hair follicle bulge coincides with LRCs and K15
expression, both in vivo markers of bulge keratinocytes. More-
over, we use an anti-CD34 antibody in combination with an
antibody to a6 integrin and FACS: (i) to isolate live bulge kerati-
nocytes, (ii) to con¢rm their quiescent nature, and (iii) to demon-
strate proliferative potential using an in vitro colony forming assay.
Due to the unique localization of CD34 expression in hair folli-
cle bulge cells, this work represents the ¢rst use of a bulge-speci-
¢c cell surface marker for physical enrichment of keratinocytes
having stem and progenitor cell characteristics.
MATERIALS AND METHODS
Animals Female FVB/N, v-Ha-ras transgenic Tg.AC, and BALB-c mice
were obtained at 4^6 wk of age from Taconic Farms (Germantown, NY),
CD-1mice (6 wk of age) from Charles River (Raleigh, NC), and C57Bl/6
mice were obtained at 6 wk of age from NCI (Frederick, Maryland). Mice
were held in our animal facility under a 12 h lightdark cycle and given
food and water ad libitum, in accordance with NIH Guidelines for Humane
Care and Use of LaboratoryAnimals.
Immunohistochemistry Formalin-¢xed mouse skin was
depara⁄nized, rehydrated, and then subjected to antigen retrieval by
steam heating for 30 min in 0.01 M citrate bu¡er (pH 6). Tissues were
incubated with either rat antimouse CD34 or rat IgG isotype control (BD
Pharmingen, San Diego, CA) at 1 : 50 for 1 h at room temperature. Signal
was detected using the Vectastain Elite Rat IgG detection kit (Vector
Laboratories, Burlingame, CA), following the manufacturer’s protocol,
with diaminobenzidine (Dako, Carpinteria, CA) as the chromagen.
Tissues were immersed in 1% CuSO4 to enhance membrane staining, and
then tissues were counterstained in Harris hematoxylin (Sigma-Aldrich, St.
Louis, MO). K15 staining was performed in Bouin’s ¢xed mouse skin,
using chicken antihuman K15 (developed by George Cotsarelis) at 1 : 100
overnight at 41C. Positive staining was detected with the ABC reagent
from the Vectastain standard detection kit (Vector Laboratories) after
incubating 30 min with biotinylated goat antichicken IgG (Jackson
ImmunoResearch Laboratories, West Grove, PA) at 1 : 100. Tissues were
counterstained with Harris hematoxylin following incubation with
diaminobenzidine.
Fluorescence staining Dorsal skin strips 2 cm by 0.5 cm from Tg.AC
mice were rolled up, epidermis side out, placed in cryovials, £ash frozen
in liquid nitrogen, and then embedded in Cryogel (Instrumedics,
Hackensack, NJ). Following acetone ¢xation and blocking of frozen
sections, tissues were incubated for 1 h at room temperature with either
primary antibody [£uorescein isothiocyanate (FITC) conjugated rat
antihuman a6 integrin (CD49f) at 1 : 300, OR FITC-conjugated rat
antimouse CD34 at 1 : 250], or FITC-conjugated isotype controls (BD
Pharmingen). Tissues were washed three times in 1 phosphate-bu¡ered
saline and coverslipped with Vectashield with DAPI (Vector Laboratories)
prior to confocal microscopy.
Confocal microscopy A laser scanning confocal microscope (LSM 410
mounted on an Axiovert 135 microscope; Carl Zeiss) was used to obtain
£uorescent images. Image stacks of roughly 15 mm through the z
dimension, at steps 1.0 mm apart, were obtained sequentially for each
£uorescent channel using a Zeiss C-Apo 40x W 1.2 DIC as the objective
lens. For FITC £uorescence, the 488 nm laser line of an Omnichrome
argonkrypton ion laser was used for excitation, and a 515^565 nm
bandpass ¢lter was used for the emission. For DAPI £uorescence, the 351
nm and 364 nm laser lines of a Coherent Enterprise argon ion laser were
used for excitation, and a 410^505 nm bandpass ¢lter was used for the
emission. Later, maximum intensity ‘‘through-focus’’ projections of the
image stacks were generated in postprocessing, and contrast-stretching
was applied uniformly across images from each channel. The software
used for acquisition was Zeiss LSM version 3.98 for Windows, and for
post-acquisition three-dimensional projections, Zeiss LSM Image
Examiner (licensed) version 2.8 forWindows NT.
Keratinocyte isolation and £ow cytometry Keratinocytes were
harvested from the dorsal skin of ¢ve mice per experiment as previously
described (Morris et al, 1990), using Tg.AC, FVB/N, C57Bl/6, BALB-c,
and CD-1 mice at 7^8 wk of age. Viable cell counts were determined
using 0.4% Trypan Blue. Keratinocytes were incubated for 30 min in the
dark at room temperature with FITC-conjugated rat antihuman a6
integrin at 20 ml per 106 cells and biotin-conjugated rat antimouse CD34
at 1 mg per 106 (BD Pharmingen). Streptavidin Cy-Chrome Conjugate
(BD Pharmingen) was added at 20 ml per 106 cells for indirect
immuno£uorescent staining of biotin-CD34 labeled cells. Non-¢xed,
intact cells were examined by £ow cytometry using a Becton Dickinson
FACSVantage SE, with propidium iodide (PI; 10 mg per ml) added to
each sample to identify cells with loss of membrane integrity. Cells were
excited with a 488 nm argon laser with an initial gate set on a forward
scatter versus PI (575/26 nm) dot plot to exclude dead cells, with 10,000
cells from the initial gate examined for each sample. a6 integrin and
CD34-Cy £uorescence were detected at 530/30 nm and 660/20 nm,
respectively, and analyzed using Cell Quest software.
Immunocytochemistry Cytospin (Shandon, Pittsburgh, PA) slides
were prepared from £ow sorted keratinocyte populations (5000 cells per
slide). Cells were ¢xed in acetone at 201C, and endogenous biotin
blocked using the Avidin/Biotin blocking kit (Vector Laboratories). For all
antibodies except vimentin, nonspeci¢c protein was blocked for 1 h using
the Vectastain Rabbit IgG kit (Vector Laboratories). Antibodies used
included rabbit anticow cytokeratin (Dako), vimentin (Dako), rabbit
antimouse K6, K14, K1, and loricrin (all from Covance, Richmond, CA).
Negative control was rabbit IgG (Vector Laboratories) at the same protein
concentration as primary antibody. Vimentin staining was accomplished
using Dako EPOS vimentin/HRP clone 3B4 with negative control
immunoglobulins conjugated to horseradish peroxidase serving to
demonstrate staining speci¢city. Antibody concentrations are given in
Table I. Frozen sections of normal mouse skin served as the positive
control for all antibodies examined.
Cell cycle analysis a6þCD34þ, a6þCD34^, and unseparated cells
were isolated by £ow cytometry, pelleted, resuspended in 5 ml of cold
70% ethanol, and stored at 41C. Ethanol-¢xed cells were pelleted, washed
Table I. Staining Properties of Flow Sorted Keratinocytes
Cell Population
Antibody (Dilution) CD34 CD34þ All Sorted
Cytokeratin (1 : 5000) þ þ þ
Vimentin (prediluted)   
Keratin 6 (1 : 4000) 7 þ 7
Keratin 14 (1 : 5000) þ þ þ
Keratin 1 (1 : 2000)   
Loricrin (1 : 2000)   
CD31 (1 : 1500)   
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once in phosphate-bu¡ered saline, and then stained with a PI solution
(20 mg per ml PI per 1000 units of RNase ONE) (Promega, Madison,
WI) for 20 min at room temperature. PI stained cells were examined
using a Becton Dickinson FACSort, with an initial gate set on a PI area
versus width dot plot for doublet discrimination. 7500 cells were examined
for each sample. Margins were set around the visible G2/M peak and
analyzed using Cell Quest software.
Colony forming assay Keratinocytes were harvested from 7-wk-old
C57Bl/6 mice, and then a6þCD34þ, a6þCD34^, and the unseparated
mixture (‘‘all sorted’’; mixture of CD34þ and CD34^ keratinocytes) were
isolated by £ow cytometry. One thousand cells per population were seeded
onto irradiated Swiss 3T3 cells in 60 mm dishes and grown at 321C/5%
CO2 in William’s E medium (Life Technologies) containing 20% fetal
bovine serum, gentamicin, and supplements. Cultures were grown for
2 wk, ¢xed in 10% NBF, (neutral bu¡ered formalin) and then stained
with 1% Rhodamine B to visualize colony growth. The remaining
cultures were grown for an additional 2 wk (total of 4 wk in culture) and
then ¢xed and stained as described above. Colony size was measured using
two dishes per population per experiment, over a total of three separate
experiments.
Reverse transcription polymerase chain reaction (RT-PCR)
detection of CD34 expression Keratinocytes from the skins of ¢ve
12-O-tetradecanoylphorbol-13-acetate (TPA) treated and ¢ve untreated
female Tg.AC mice were harvested and subjected to £ow cytometric
analysis as described above. The shaved dorsal skin surface was dosed
with 5 mg TPA (Sigma Aldrich, St. Loius, MO) in 200 ml acetone
twice weekly for 2 wk, and then keratinocytes were harvested 24 h
after the last treatment. Cells were pelleted and £ash frozen in liquid
Figure1. Localization of CD34 expression, LRCs, and K15 expression in murine hair follicles. (A) CD34 expression in formalin-¢xed, para⁄n-
embedded dorsal skin from an untreated Tg.AC mouse, showing membrane localization in the hair follicle. Arrow indicates CD34-positive cells. (B) For-
malin-¢xed skin from a CD-1 mouse injected with tritiated thymidine followed by a 10 wk chase. Arrow indicates LRCs. (C) K15 expression in Bouin’s
¢xed, para⁄n-embedded skin from an untreated Tg.AC mouse. Arrow indicates K15-positive bulge keratinocytes. (D) CD34 expression in a murine telogen
hair follicle. (E) CD34 expression in a murine anagen hair follicle. Arrow indicates CD34-positive keratinocytes in panels D and E. Scale bars: 100 mm.
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nitrogen, and total RNAwas extracted using the MicroRNA Isolation kit
(Stratagene, La Jolla, CA); then cell populations were analyzed
for CD34 expression. Following reverse transcription (421C 15 min,
991C 5 min, and 41C 5 min), samples were ampli¢ed (35 cycles:
941C 30 s, 551C 30 s, and 721C 1 min). Primers were as follows: antisense
50 -GCTCTCTGCCTGATGAGTCTG and sense 50 -CCCTTAATGGCAC-
TCGGAGC, generating a 455 bp product. RNA integrity was assessed
using expression of mouse b2 microglobulin as previously described
(Battalora et al, 2001).
Statistical analysis Comparisons of relative a6-FITC £uorescence
between a6þCD34þ and a6þCD34^ keratinocytes were carried out
by paired Student’s t tests, using £uorescence data from six separate
experiments. Keratinocytes were harvested in all six experiments from 7-
wk-old C57Bl/6 mice. For comparisons of colony size between
keratinocyte populations, analysis of variance was used to assess the
signi¢cance of colony size di¡erences, replicate variability, and the
interaction between the two factors. The variance-stabilizing logarithmic
transformation was used in these analyses.
RESULTS
CD34 expression in the follicular bulge region
Immunostaining of formalin-¢xed, para⁄n-embedded skin
taken from normal, untreated Tg.AC mice revealed intense
membrane localization of CD34 in the hair follicle bulge
(Fig 1A). The area of CD34 staining coincided with the location
of LRCs, which mark slowly cycling KSCs in vivo (Cotsarelis et
al, 1990; Morris and Potten, 1999) (Fig 1B), and with K15
expression, which is preferentially expressed in the hair follicle
bulge in human and mouse skin (Lyle et al, 1998; Porter et al,
2000) (Fig 1C). A similar pattern of CD34 expression was found
in skin from FVB/N, C57Bl/6, DBA/2, CD-1, BALB-c, and
SENCAR mice (data not shown). Expression of CD34 is
prominent during telogen and is also evident in anagen hair
follicles (Fig 1D, telogen; Fig 1E, anagen). We did not detect
expression in other hair follicle structures such as the bulb, or in
the interfollicular epidermis.
To characterize further CD34 expression in mouse skin, we
used an FITC-conjugated form of the antibody on frozen
sections for direct labeling (Fig 2A).With confocal microscopy,
we show similar membrane localization in the hair follicle
(Fig 2A). Figure 2(B) represents merged images of CD34-
FITC (green) and DAPI (blue) staining to highlight the nuclei
and orient CD34 expression in the follicle (E, epidermis; D,
dermis; HF, hair follicle, B, bulge; HS, hair shaft). We also
examined a6 integrin, using an FITC-conjugated antibody, to
demonstrate that a6 integrin is expressed only on basal
keratinocytes (Fig 2D, E represents the merged images of a6-
FITC staining and DAPI). As described below, this characteristic
a6 integrin expression was used in £ow cytometric analysis
of keratinocytes, to exclude suprabasal cells as well as
nonkeratinocytes. Figure 2(C), (F) shows FITC-conjugated
isotype control (rat IgG), the negative control for CD34-FITC,
and a6-FITC staining, respectively. In panels C and F, the dotted
line marks the epidermaldermal junction and the hair shafts are
labeled (HS), highlighting the lack of staining in the sections
using isotype controls.
Isolation and characterization of a6þCD34þ cells isolated
from mouse keratinocytes When harvested keratinocytes
were stained with antibodies to a6 integrin (FITC conjugate)
and CD34 (biotin conjugate, with Streptavidin-CY secondary)
Figure 2. Fluorescence detection of CD34 expression and a6 integrin in mouse skin. Frozen dorsal skin sections were stained with either FITC-
conjugated CD34 or FITC-conjugated a6 integrin, coverslipped with mounting medium containing DAPI, and subjected to confocal microscopy for
imaging. (A) CD34-FITC staining in hair follicle. (B) CD34-FITC staining merged with DAPI to highlight epidermal and follicular nuclei. E, epidermis;
D, dermis; HF, hair follicle; B, bulge. (C) Isotype control (rat IgG-FITC) for CD34. HS, hair shaft. (D) a6 integrin-FITC, with signal localized to the
basement membrane aspect of basal keratinocytes. (E) a6-FITC staining merged with DAPI. (F) Isotype control (rat IgG-FITC) as negative control for a6
integrin staining. Scale bars: 50 mm.
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and then subjected to FACS analysis, a distinct and reproducible
a6þCD34þ population was found, which comprised 7%^8%
of a6þ keratinocytes and is shown in the upper right quadrant
of Fig 3(A). Most of the cells were a6þCD34^ (approximately
64%), as shown in the lower right quadrant of the plots. A small
population (approximately 2%^3%) of a6^CD34þ cells was also
found, as shown in the upper left quadrant of the plots (Fig 3A).
This population was not consistently observed when the cells
were analyzed using CD34-FITC and a6 integrin directly
conjugated to CY-5 (BD Pharmingen). No change was observed
with respect to the a6þCD34þ population, however, when the
£uors were switched (data not shown), demonstrating the
validity and reproducibility of this population of cells and
therefore strengthening our data.
Because monoclonal antibodies may cross-react with proteins
unrelated to their original targets (Kramer et al, 1997; Weinberg
and Yuspa, 1997; Lyle et al, 1998), and because CD34 expression
in keratinocytes has not been previously reported, we con¢rmed
Figure 3. Analysis of a6/CD34 expression in various mouse strains by £ow cytometry. (A) Keratinocytes were isolated from 7- to 8-wk-old Tg.AC,
C57Bl/6, FVB/N, BALB/c, and CD-1 mice, stained with a6 integrin-FITC and CD34-Cy and examined by £ow cytometry. Negative controls were pre-
pared using isotype control antibodies to determine staining speci¢city (not shown). a6þCD34þ cells are shown in the upper right-hand quadrant of each
contour plot, whereas a6þCD34^ cells are shown in the lower right-hand quadrant, with percentage of each sorted cell population for all ¢ve strains
examined listed. (B) Analysis of CD34 expression by RT-PCR (upper panel, 455 bp product). Lanes 1, 4, unseparated cells; lanes 2, 5, CD34^ cells; lanes 3, 6,
CD34þ cells (from TPA-treated and untreated skin, respectively); lane 7, positive control (spleen). Lower panel shows mouse b2 microglobulin (212 bp)
expression to assess RNA integrity.
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the speci¢city of the CD34 antibody used in these experiments.
Because steady-state expression of CD34 message is correlated to
the presence of cell surface CD34 (Krause et al, 1994), we analyzed
the sorted cell populations for expression of the CD34 message in
cells harvested from bothTPA-treated and nontreated mouse skin
using RT-PCR (Fig 3B). We examined cells from treated and
untreated mice in order to assess whether the CD34 mRNA
expression pattern would be a¡ected by the proliferative status
of the skin. CD34 expression was detected in the unseparated
mixture (Fig 3B, upper panel, lanes 1, 4) and in CD34þ cells
(lanes 3, 6). Only faint product was evident in CD34^ cells (lanes
2, 5), probably re£ecting the presence of contaminating CD34þ
cells and highlighting the sensitivity of the PCR ampli¢cation.
RNA integrity was assessed with expression of mouse b2-
microglobulin (Fig 3B, lower panel). Therefore, we con¢rmed the
presence of CD34 mRNA in the sorted population in both
untreated and TPA-treated skin, and demonstrated the speci¢city
of the CD34 antibody used in £ow cytometry experiments.
Furthermore, we found that the compartmentalization of CD34
mRNA expression in CD34þ keratinocytes did not change in
TPA-treated skin.
To address further the speci¢city of the antibody used in these
studies, we stained formalin-¢xed sections of mouse skin with an
antibody against CD34 from a di¡erent source (rat antimouse
CD34, catalog number ab8158-100, Abcam, Cambridge, U.K.).
We found similar localization of expression to bulge
keratinocytes in the hair follicle (data not shown). Therefore,
based on the expression of the CD34 in CD34þ sorted cells,
and similar location to bulge cells using a di¡erent CD34
antibody, we conclude that the antibody used in immuno-
histochemistry and £ow cytometry is speci¢cally recognizing
the CD34 epitope on harvested keratinocytes.
Stem and progenitor cells would be expected to express higher
levels of integrins to facilitate attachment to the basement
membrane. Previous investigators have identi¢ed a subset of
keratinocytes expressing relatively high levels of b1 integrin that
Figure 4. Analysis of a6 integrin £uorescence in CD34þ and CD34^ keratinocytes. Keratinocytes were isolated from C57B1/6 Mice, stained with a6
integrin-FITC and CD34-Cy, and examined by £ow cytometry. a6þCD34þ and a6þCD34^ were gated as described in Fig 3. (A) Contour plot demon-
strating relative increase in a6 £uorescence in CD34þ cells compared to CD34^ cells. (B) Quantitation of a6 £uorescence in CD34þ and CD34^ cells. The
mean a6-FITC £uorescence for each individually gated population of cells was determined using CellQuest software.
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are thought to be stem cells (Jones and Watt, 1993). This has
not been observed with a6 integrin (Li et al, 1998). To determine
if a di¡erence in a6 integrin expression was present in our
CD34þ cells, we examined the relative mean a6-FITC
£uorescence of CD34þ and CD34^ keratinocytes using data
collected from six individual experiments, with cells collected
from 7-wk-old C57Bl/6 mice (Fig 4). Examination of
keratinocytes stained with a6 and CD34 did show a detectable
increase in a6 levels in the CD34þ population (Fig 4A).
Quantitation of a6þCD34þor a6þCD34^ cells from six
di¡erent experiments showed that CD34þ cells had a
statistically signi¢cant (po0.05) increase in the level of a6
£uorescence compared to CD34^ cells (Fig 4B). Although
variability in the degree of increased a6 £uorescence was
observed in any given experimental pair, an overall increase in
the level of a6 expression was always observed between
the CD34þ and CD34^ cells. This trend was also apparent
in cells harvested from other strains as well (data not shown).
The consistency of this observation over six separate
experiments using C57Bl/6 mice from di¡erent litters
strengthens the ¢nding. In spite of the fact that the di¡erence in
mean channel £uorescence is small, it was statistically signi¢cant
Figure 5. Cell cycle analysis of a6 integrin, CD34 stained mouse keratinocytes. Cells were isolated from 7-wk-old C57Bl/5, BALB-c, and CD-1
mice and examined for changes in DNA content. (A) Representative histograms derived from a6þCD34þ, a6þCD34^, and ‘‘all sorted’’cells from 7-wk-
old C57Bl/6 mice. (B) Dot plot analysis of the three cell populations (G2/M, G0/G1, and S phase) derived from three mouse strains (C57Bl/6, BALB-c, and
CD-1).
Table II. Keratin 6 and 14 Staining Incidence in Flow Sorted
Keratinocytes
% Positive Cells
Cell Population Keratin 6a Keratin 14
CD34þ 99.0 99.0
97.0 97.0
98.0 98.0
Mean7SD 98.071.0 98.071.0
CD34 6.0 100.0
7.0 100.0
8.0 100.0
Mean7SD 7.071.0 100.070.0
All Sort 15.0 92.0
11.0 92.0
12.0 100.0
Mean7SD 12.772.1 94.774.6
a300 to 500 consecutive cells were counted using a Zeiss Axioplan microscope
and 100 magni¢cation, for three separate experiments K6- or K14-stained per
cell population.
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(po0.05). These data indicate that a6þCD34þ cells comprise a
subset of the a6-integrin-positive population that have high
levels of a6 integrin expression.
Because CD34 is expressed on other cell populations in the
skin, such as endothelial and dendritic cells (Nickolo¡, 1991), we
con¢rmed that our cell sorting strategy was preferentially
isolating keratinocytes by staining cytospin preparations
with antibodies to various cytokeratins, vimentin, and CD31
(Table I). All £ow-sorted subpopulations were positive for a
broad spectrum cytokeratin antibody as well as K14 (Tables I,
II), speci¢c for basal cells (Fuchs and Green, 1980). In addition,
the cells were positive for K6, although a6þCD34þ were
enriched compared to a6þCD34^ cells (Tables I, II),
demonstrating that CD34þ cells were follicular in origin (Roop
et al, 1984). All of the cell populations were negative for K1, an
early di¡erentiation marker (Roop et al, 1983; Regnier et al, 1986),
for loricrin, expressed only in terminally di¡erentiated stratum
granulosum cells (Mehrel et al, 1990; Fuchs and Byrne, 1994), and
for vimentin (Langa et al, 2000), expressed in cells of
mesenchymal origin. To assess further the incidence of K6 and
K14 staining in the £ow-sorted cell populations, antibody-
stained slides from three separate experiments were examined
for the numbers of keratin-positive cells (Table II). Three
hundred to ¢ve hundred consecutive cells were counted using a
Zeiss Axioplan microscope (Carl Zeiss, Thornwood, NY) at
100magni¢cation and the percentage of keratin-positive cells
was calculated (Table II). Virtually all cells from all three
populations were K14 positive, as expected of cells derived from
the basal keratinocyte compartment. In contrast, only 7%71%
and 12%72% of the CD34^ and all sort cells, respectively, were
K6 positive, whereas 98%71% of the CD34þ cells were found
to express K6, demonstrating the enrichment for follicular cells
using CD34 and a6 integrin antibodies.
Finally, cells were assessed for expression of the endothelial
cell determinant CD31 (Albeda et al, 1991). All sorted cells
were negative for CD31 expression (Table I). Hence, double
immunostaining with a6 and CD34 in combination with FACS
enabled us to isolate a minor subpopulation of basal keratinocytes
derived from the hair follicle bulge.
a6þCD34þ cells are quiescent and form large colonies in
culture In the skin, stem cells are thought to be normally
slowly cycling to provide for long-term tissue maintenance as
well as to persist over the lifetime of the animal (Lavker et al,
1993; Lavker and Sun, 2000; Fuchs and Raghavan, 2002).
Because CD34 expression localized to a subset of cells in the
hair follicle bulge region and appeared to identify LRCs, we
were interested in characterizing the cell cycle properties of
these cells. Figure 5 summarizes the cell cycle analysis of a6,
CD34 sorted cells from three di¡erent mouse strains.
a6þCD34þ cells were enriched for cells in G0/G1 relative to
a6þCD34^ cells, and had few cells in S phase and G2/M,
consistent with quiescence (Fig 5). In addition, CD34þ cells
were smaller than CD34^ cells (data not shown), suggesting a
more primitive morphology. Hence, our results demonstrate that
a6þCD34þ cells are small, slowly cycling cells, properties of
stem and progenitor cells.
When sorted keratinocytes were seeded at clonal density, both
CD34þ and CD34^ cells formed colonies, as did the unseparated
(all sorted) cells (Fig 6). After 2 wk in culture, there was little if
Figure 6. Colony growth of a6 integrin, CD34 stained keratinocytes. Keratinocytes were harvested from 7-wk-old female C57Bl/6 mice and sorted
using FACS under sterile conditions. CD34þ, CD34^, and the unseparated mixture (‘‘all sorted’’) were grown for 4 wk on irradiated Swiss 3T3 cells, ¢xed
in 10% NBF, and stained with Rhodamine B to visualize colony growth.
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any di¡erence in colony size among the three populations. After
4 wk, however, there was a clear enrichment for larger colonies
from CD34þ keratinocytes (Fig 6; Table III), indicating a
higher proliferative potential for CD34þ keratinocytes. Analysis
of variance, using data from all three experiments, revealed a
signi¢cant (po0.05) di¡erence in colony size between the
CD34þ and CD34^ populations. Although this di¡erence was
evident in all three experiments, the actual magnitude of the
colony size di¡erences varied signi¢cantly (po0.05) among the
three experiments (Table III). Despite the small sample size,
however, there was a statistically signi¢cant di¡erence in colony
size between the two populations, indicating that CD34þ
keratinocytes consistently form larger colonies in clonogenic
culture than CD34^ cells. Taken together, we conclude that
CD34 identi¢es a slowly cycling population of hair follicle
bulge keratinocytes that form large colonies in cultures, evidence
that CD34 is a determinant for keratinocytes with stem and
progenitor cell characteristics.
DISCUSSION
We report here that the hematopoietic stem and progenitor cell
determinant, CD34, localizes to the bulge region in mouse skin,
and in combination with a6 integrin identi¢es a minor popula-
tion of slowly cycling keratinocytes.
The bulge is a heterogeneous collection of cells in the middle
permanent region of the hair follicle, and it is widely considered
to be the location of KSCs (Cotsarelis et al, 1990; Morris and
Potten, 1994; Lavker and Sun, 2000). Besides being protected
from wounding or environmental damage, the bulge creates an
area isolated from the changes that occur to the follicle as it cycles
from anagen (active growth) to telogen (resting), providing a
sequestered microenvironment for stem cells. Moreover, Oshima
et al (2001) elegantly demonstrated that bulge keratinocytes of
vibrissa follicles can produce the hair follicle, sebaceous gland,
and the interfollicular epidermis.
It is generally accepted that LRCs mark KSCs in vivo (Cotsar-
elis et al, 1990; Morris and Potten, 1999; Lavker and Sun, 2000).
The skin of neonatal mice receiving repeated injections of
3H-thymidine followed by a long chase period retains the label
in cells sequestered in the bulge region, with very few labeled
cells found in the interfollicular epidermis. This supports the
hypothesis that these cells are slowly cycling and most likely
represent a stem cell population. Moreover, an ability to respond
to proliferative stimuli supports the role stem cells play in main-
taining tissue homeostasis and regeneration over the lifetime
of the animal (Cotsarelis et al, 1999). This was demonstrated by
Morris and Potten (1994), who showed that LRCs in vivo are clo-
nogenic in vitro (Morris and Potten, 1994). In contrast, theTA cells
identi¢ed by pulse labeling do not form large colonies in culture.
Therefore, LRCs in the hair follicle bulge represent slowly cy-
cling cells with a high proliferative capacity, both well recognized
hallmarks of stem cells.
Bulge cells express both K19 (Lane et al, 1991; Michel et al, 1996)
and K15 (Lyle et al, 1998). Nevertheless, K19 expression is not un-
ique to the bulge because, during hair growth, expression extends
down the outer root sheath. Lyle et al (1998) observed that K15-
expressing cells remain localized to the bulge region in human
skin regardless of the growth stage, and are a subset of K19 cells
in the follicle. In resting follicles, K15 and K19 are colocalized,
suggesting K15 cells in the bulge give rise to K19 cells (Lyle et al,
1998), but further studies are necessary to determine a progen-
itorprogeny relationship. In addition, K15-expressing bulge
keratinocytes were found to correspond to LRCs and express
high levels of b1 integrin, suggesting that this is a population of
stem and progenitor cells (Lyle et al, 1998).
The expression pattern and colocalization of CD34 with K15
and LRCs in the hair follicle bulge suggested that this cell surface
marker might be a selectable determinant for living follicular
keratinocytes (neither K15 protein nor LRCs enable this selec-
tion). Cell populations with stem-cell-like properties can be iso-
lated from primary keratinocytes using cell surface markers in
combination with £ow cytometry, including b1 integrin (Jones
andWatt, 1993), and a negative selection strategy using a6 integ-
rin in combination with CD71 (Tani et al, 2000). CD34, used
with b1 integrin, identi¢es a subset of b1 integrinþCD34þ cells
(data not shown); however, the use of a6 integrin with CD34
enables positive selection for follicular bulge cells and enriches
this population. Furthermore, our analysis provides evidence of
a subset of a6 integrin bright cells not apparent in cells stained
with a6 alone (Li et al, 1998). KSCs may express more integrin
in order to maintain tight adherence to the basement membrane,
as evidenced by b1 integrin expression (Jones and Watt, 1993).
Therefore, our ¢nding that CD34 identi¢es an a6 integrin bright
subset supports the hypothesis that this population of bulge kera-
tinocytes has characteristics in common with stem and progeni-
tor cells.
It has been proposed that very earlyTA cells in the hair follicle
are undi¡erentiated enough to still retain a high proliferative
potential (Taylor et al, 2000). One measure of that capacity is the
use of in vitro assays for colony formation (Rheinwald and Green,
1975; Barrandon and Green, 1987; Mathor et al, 1996). Because the
basal epidermis is composed of a continuum of cells with varying
degrees of proliferative capacity (Oshima et al, 2001; Taylor et al,
2000), many basal keratinocytes will form colonies after 2 wk in
culture. The size of the colonies after 4 wk, however, re£ects the
proliferative capacity of the cell of origin. It has been demon-
strated that LRCs are clonogenic in vitro, whereas TA cells identi-
¢ed by pulse labeling do not form colonies in culture (Morris
and Potten, 1994). Based on our observations that CD34þ cells
form large colonies in culture relative to those formed by
CD34^, we conclude that CD34þ keratinocytes have a higher
proliferative potential than CD34^ keratinocytes. In addition,
the increased a6 integrin expression in CD34þ cells may also in-
dicate a higher proliferative potential, based on previous evidence
that the highest colony forming activity was distributed in kera-
tinocytes expressing the highest levels of b1 integrin (Jones and
Watt, 1993). Finally, the a6þCD34þ cells, based on the distribu-
tion of CD71 expression, most probably represent a subset of
a6briCD71dim cells, which were shown to be slowly cycling LRCs
(Tani et al, 2000).
A recent paper by Albert et al (2001) suggested that CD34 is
not expressed in murine keratinocytes, in direct opposition to
our study conclusions. The apparently con£icting data probably
re£ect di¡erences in methodology. Using their ¢xation method,
we con¢rmed their results (data not shown), suggesting that
at least one fundamental di¡erence lies in our use of non¢xed,
intact cells.
Table III. Colony size of £ow sorted keratinocytes grown in
clonogenic culture
Cell population Experiment 1 Experiment 2 Experiment 3
Alpha-6þCD34þ 8.6273.73 (20)a,b,c 5.3772.44 (22) 6.2373.42 (29)
7.8574.46 (25) 5.5672.84 (17) 5.7372.64 (40)
Alpha-6þCD34 4.8172.57 (30) 3.9871.73 (38) 4.8772.05 (34)
4.3972.02 (30) 3.8471.74 (38) 4.6572.03 (35)
All Sorted 3.4071.24 (57) 3.2871.02 (25) 4.5071.86 (50)
4.1871.76 (60) NDd 5.2072.00 (50)
aMean colony diameter in mm7SD (number of colonies per dish).
bMeasurements were taken from colonies grown in two 60 mm dishes per po-
pulation per experiment after 4 weeks in culture.
cAnalysis of Variance (ANOVA) was used to assess the signi¢cance of colony
size di¡erences between alpha-6þCD34þ and alpha-6þCD34 keratinocytes
over all three experiments. Variability and the interaction between experiments
and colony size were also assessed. ANOVA revealed a signi¢cant (po0.05) di¡er-
ence between the alpha-6þCD34þ and alpha-6þCD34 populations in the
three experiments. There was also a signi¢cant (po0.05) interaction experiments
and colony size, indicating that the actual magnitude of the colony size di¡erences
varied from experiment to experiment.
dNo data.
HAIR FOLLICLE BULGE AND EXPRESSION OF CD34 509VOL. 120, NO. 4 APRIL 2003
The ability to harvest keratinocyte stem cells from the skin has
highly signi¢cant implications with respect to gene therapy
applications. In order to accomplish long-term changes in gene
expression, it is necessary to target slowly cycling stem cells be-
cause TA cells are rapidly removed from the proliferative pool
through terminal di¡erentiation. Therefore, targeting proliferat-
ing cells results in only transient expression. To date, there have
been no cell surface determinants capable of targeting the speci¢c
localization of keratinocyte stem cells. Our work with CD34 not
only demonstrates speci¢c localization to the hair follicle bulge,
but also suggests that these cells behave like stem and progenitor
cells in that they are quiescent, form large colonies in culture, and
express relatively more a6 integrin compared to CD34^ cells. In
addition, CD34 expression remains localized to the hair follicle,
with no evidence of expression in the interfollicular epidermis,
making it a tool for isolating and collecting this speci¢c popula-
tion of cells, o¡ering the potential of precise targeting of the cell
population necessary for the development of ex vivo gene therapy
applications.
In summary, our ¢ndings demonstrate that the cell sur-
face marker CD34 can be used for the physical enrichment of
a population of follicular cells with stem or progenitor cell cha-
racteristics, such as quiescence, high proliferative capacity, and
localization in a protected microenvironment. Although the role
of CD34 in keratinocytes of the hair follicle bulge is unknown,
further investigation of the functional properties of this cell sur-
face marker may well provide insights into stem cell biology as it
pertains to the hair follicle.
We have shown that CD34 expression is localized to the same
region of the hair follicle as LRCs using immunohistochemical
and autoradiographic techniques. We have recently isolated
CD34þ and CD34 keratinocytes by FACS from 10-week-old
CD-1 mice injected with tritiated thymidine as 3- to 6-day-old
pups. From this, we have determined that 65% of the LRC cells
are found in the CD34þ population, while 7% LRC are in the
CD34 population, directly con¢rming that CD34þ keratino-
cytes are enriched for label retaining cells.
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